Paper42875487PubMed
Computational design of metalloproteases.
Chen A and 27 others. Nature, 2026.
Cite this record
ConductScience Library. Computational design of metalloproteases. Papers, record 42875487. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42875487
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Computational design of metalloproteases.
- Journal
- Nature
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-27
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Update of | 41332769 | Computational design of metalloproteases. | https://conductscience.org/library/papers/41332769 |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30545884 | Evolution of a highly active and enantiospecific metalloenzyme from short peptides. | Science | 2018 | https://conductscience.org/library/papers/30545884 | PubMed |
| 2 | 41339547 | Computational design of metallohydrolases. | Nature | 2026 | https://conductscience.org/library/papers/41339547 | PubMed |
| 3 | 7957888 | Families of zinc metalloproteases. | FEBS Lett | 1994 | https://conductscience.org/library/papers/7957888 | PubMed |
| 4 | 11848831 | Recent Advances in Zinc Enzymology. | Chem Rev | 1996 | https://conductscience.org/library/papers/11848831 | PubMed |
| 5 | 17318226 | Matrix metalloproteinases and the regulation of tissue remodelling. | Nat Rev Mol Cell Biol | 2007 | https://conductscience.org/library/papers/17318226 | PubMed |
| 6 | 18762209 | The ADAM metalloproteinases. | Mol Aspects Med | 2008 | https://conductscience.org/library/papers/18762209 | PubMed |
| 7 | 38071234 | Role of ADAM and ADAMTS proteases in pathological tissue remodeling. | Cell Death Discov | 2023 | https://conductscience.org/library/papers/38071234 | PubMed |
| 8 | 19461648 | Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis. | Hypertens Res | 2009 | https://conductscience.org/library/papers/19461648 | PubMed |
| 9 | 23813340 | Purification and characterization of a new metallo-neutral protease for beer brewing from Bacillus amyloliquefaciens SYB-001. | Appl Biochem Biotechnol | 2013 | https://conductscience.org/library/papers/23813340 | PubMed |
| 10 | 21847327 | Guidelines for the use of botulinum toxin in movement disorders and spasticity. | Ann Indian Acad Neurol | 2011 | https://conductscience.org/library/papers/21847327 | PubMed |
| 11 | 12875934 | Botulinum toxin as a new therapy option for voiding disorders: current state of the art. | Eur Urol | 2003 | https://conductscience.org/library/papers/12875934 | PubMed |
| 12 | 31114283 | Botulinum toxin (Botox) A for reducing the appearance of facial wrinkles: a literature review of clinical use and pharmacological aspect. | Clin Cosmet Investig Dermatol | 2019 | https://conductscience.org/library/papers/31114283 | PubMed |
| 13 | 25852691 | 4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer. | Front Immunol | 2015 | https://conductscience.org/library/papers/25852691 | PubMed |
| 14 | 36677656 | Ultrafast Spectroscopies of Nitrophenols and Nitrophenolates in Solution: From Electronic Dynamics and Vibrational Structures to Photochemical and Environmental Implications. | Molecules | 2023 | https://conductscience.org/library/papers/36677656 | PubMed |
| 15 | 37433327 | De novo design of protein structure and function with RFdiffusion. | Nature | 2023 | https://conductscience.org/library/papers/37433327 | PubMed |
| 16 | 39636970 | Target-conditioned diffusion generates potent TNFR superfamily antagonists and agonists. | Science | 2024 | https://conductscience.org/library/papers/39636970 | PubMed |
| 17 | 39814879 | De novo designed proteins neutralize lethal snake venom toxins. | Nature | 2025 | https://conductscience.org/library/papers/39814879 | PubMed |
| 18 | 41193805 | Atomically accurate de novo design of antibodies with RFdiffusion. | Nature | 2026 | https://conductscience.org/library/papers/41193805 | PubMed |
| 19 | 25192493 | Structure-guided, single-point modifications in the phosphinic dipeptide structure yield highly potent and selective inhibitors of neutral aminopeptidases. | J Med Chem | 2014 | https://conductscience.org/library/papers/25192493 | PubMed |
| 20 | 38718835 | Accurate structure prediction of biomolecular interactions with AlphaFold 3. | Nature | 2024 | https://conductscience.org/library/papers/38718835 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42875487
GET https://conductscience.org/api/papers/v1/42875487/authors?page=2